Join
Live feed
·
INSIDERFilingvia Quantisnow
Sage Therapeutics Inc. logo

SEC Form 4: Barrett Elizabeth bought $37,279 worth of shares (2,000 units at $18.64), increasing direct ownership by 200% to 3,000 units

ByQuantisnow·Wall Street's wire, on your screen.
SAGE· Sage Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SAGE (Sage Therapeutics Inc.) and more on Quantisnow.